Analysis of Relapse-Associated Alternative Mrna Splicing and Construction of a Prognostic Signature Predicting Relapse in I–III Colon Cancer

Zhiyuan Zhang,Qingyang Feng,Caiwei Jia,Peng Zheng,Yang Lv,Yihao Mao,Yuqiu Xu,Guodong He,Jianmin Xu
DOI: https://doi.org/10.1016/j.ygeno.2020.07.002
IF: 4.31
2020-01-01
Genomics
Abstract:The literature comprehensively analyzed alternative splicing (AS) events in colon cancer is little and corresponding prognostic signature is still a lack. Based on data of TCGA, the relapse-associated ASs were comprehensively analyzed and a signature was further constructed to predict the relapse in I-III colon cancer. In total 1912 ASs of 1384 mRNA were identified as relapse-associated ASs, protein-protein interactions (PPI) and ASs-splicing factors (SF) interactions network were identified. We finally built a robust signature to predict the relapse of I-III colon cancer with a considerable AUC value in both the training group and the test group. The AUC in the entire set at 1, 3 and 5 year was 0.85, 0.83 and 0.836. Our study provided a profile of relapse-associated ASs in I-III colon cancer and built a robust signature to predict the relapse of I-III colon cancer.
What problem does this paper attempt to address?